Schedule 13D ownership disclosure

Keros Therapeutics Inc

Security class unavailable · CUSIP: 492327101

Event date: 2022-11-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-22-001141
Form type
SC 13D/A
Filer
Keros Therapeutics, Inc.
CIK
CIK 1664710
Filed
Nov 07, 2022
Reporting period
Nov 03, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub